Committee for Medicinal Products for Human Use

Results: 188



#Item
91Pioglitazone / Chemistry / European Medicines Agency / Anti-diabetic medication / Committee for Medicinal Products for Human Use / Research / Pharmacology / Rosiglitazone / Pyridines / Thiazolidinediones / Eli Lilly and Company

9 June 2011 EMA[removed]Press Office Press release

Add to Reading List

Source URL: www.ema.europa.eu

Language: English - Date: 2013-07-21 06:15:52
92Pharmaceutical industry / Medicine / Research / Health / Eli Lilly and Company / Pioglitazone / Committee for Medicinal Products for Human Use / European Medicines Agency / Bladder cancer / Thiazolidinediones / Pyridines / Clinical research

Actos end of art 20 - press release

Add to Reading List

Source URL: www.ema.europa.eu

Language: English - Date: 2013-07-21 06:17:08
93Pharmaceutics / European Medicines Agency / Pharmaceutical sciences / Validity / Validation / Committee for Medicinal Products for Human Use / Clinical research / Pharmaceutical industry / Research

Qualification of novel methodologies for drug development: guidance to applicants

Add to Reading List

Source URL: c-path.org

Language: English - Date: 2014-02-20 17:49:57
94Medicine / Anti-diabetic drugs / Diabetes / Eli Lilly and Company / Pancreatic hormones / European Medicines Agency / Liraglutide / Committee for Medicinal Products for Human Use / Glucagon-like peptide-1 / Peptide hormones / Endocrine system / Biology

24 July 2014 EMA/CHMP[removed]Committee for Medicinal Products for Human Use (CHMP) Summary of opinion 1 (initial authorisation)

Add to Reading List

Source URL: www.ema.europa.eu

Language: English - Date: 2014-07-25 07:07:29
95Celecoxib / Organofluorides / Pfizer / Pyrazoles / Sulfonamides / European Medicines Agency / Committee for Medicinal Products for Human Use / Familial adenomatous polyposis / Polyp / Medicine / Oncology / COX-2 inhibitors

20 May 2011 EMA/CHMP[removed]Press Office Press release

Add to Reading List

Source URL: www.ema.europa.eu

Language: English - Date: 2013-07-21 06:15:05
96Endocrine system / Peptide hormones / Recombinant proteins / Insulin / Humulin / Committee for Medicinal Products for Human Use / European Medicines Agency / Diabetes mellitus / Insulin therapy / Eli Lilly and Company / Biology / Medicine

European Medicines Agency Press office London, 16 January 2008 Doc. Ref. EMEA[removed]

Add to Reading List

Source URL: www.ema.europa.eu

Language: English - Date: 2013-07-21 05:04:58
97Pharmaceutical sciences / European Medicines Agency / Peginterferon alfa-2a / Interferon / Committee for Medicinal Products for Human Use / Peginterferon alfa-2b / Pharmacovigilance / Ribavirin / Hepatitis B / Antivirals / Pharmacology / Medicine

The role of EMA and drug approvals for chronic HBV/HCV Summit Conference Hepatitis B and C Brussels, 14-15 October[removed]Marco Cavaleri

Add to Reading List

Source URL: www.hepbcppa.org

Language: English - Date: 2014-04-30 06:48:45
98Pharmaceutical industry / Pharmaceutical sciences / Pharmacology / Low molecular weight heparin / Biotechnology / European Medicines Agency / Committee for Medicinal Products for Human Use / Biosimilar / Biologic / Heparins / Clinical research / Research

Concept paper on the revision of the guideline on nonclinical and clinical development of similar biological medicinal products containing low-molecular-weight heparins

Add to Reading List

Source URL: www.ema.europa.eu

Language: English - Date: 2013-07-21 06:17:34
99Pharmaceutics / European Medicines Agency / Pharmaceutical sciences / Validity / Validation / Committee for Medicinal Products for Human Use / Clinical research / Pharmaceutical industry / Research

Qualification of novel methodologies for drug development: guidance to applicants

Add to Reading List

Source URL: www.ema.europa.eu

Language: English - Date: 2014-01-08 07:18:20
100Medicine / Peptide hormones / Recombinant proteins / Diabetes / Clinical research / Insulin analog / Insulin / Committee for Medicinal Products for Human Use / European Medicines Agency / Biology / Eli Lilly and Company / Endocrine system

Concept paper on the revision of the guideline on nonclinical and clinical development of similar biological medicinal products containing recombinant human insulin

Add to Reading List

Source URL: www.ema.europa.eu

Language: English - Date: 2013-07-21 06:17:35
UPDATE